AIS Clinical Trial
Official title:
Screening and Intervention for Adolescent Idiopathic Scoliosis in Haikou, Hainan Province, China
This is a single-center, prospective, non-randomized, open-label, interventional, real-world study. The mild/moderate AIS patients will be recruited through screening of 250,000 primary and secondary school students in Haikou, Hainan Province. The patients will be treated with different non-surgical interventions (exercise intervention or brace intervention) according to the physician's recommendations and the patient's intention. Patients will be followed up for 36 months to evaluate the effectiveness and safety of non-surgical interventions in the real world.
Status | Recruiting |
Enrollment | 5000 |
Est. completion date | December 31, 2026 |
Est. primary completion date | December 31, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 9 Years to 16 Years |
Eligibility | Inclusion Criteria: 1. 9 years = age = 16 years 2. Diagnosis of AIS 3. 10°=Cobb's angle<45° 4. Signed informed consent form Exclusion Criteria: 1. With other developmental disorders, musculoskeletal disorders, nerve disorders, infection disorders, mental disorders, and other disorders 2. Obvious deformity of lower limbs and(or) feet 3. Previous or ongoing treatment of AIS 4. Difficulty to read, understanding, and complete the study questionnaires 5. Any criteria, which, in the opinion of the investigator, suggest that the subject would not be compliant with this study protocol |
Country | Name | City | State |
---|---|---|---|
China | Haikou orthopedic and diabetes hospital, Haikou orthopedic and diabetes hospital of Shanghai Sixth People's Hospital | Haikou | Hainan |
Lead Sponsor | Collaborator |
---|---|
Chaoyin Jiang |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Correlation between the age and the out-of-control rate of treatment | Correlation between the patient's age and the out-of-control rate of treatment | 36 months | |
Other | Correlation between the BMI at baseline and the out-of-control rate of treatment | Correlation between the patient's BMI (kg/m^2) at baseline and the out-of-control rate of treatment | 36 months | |
Other | Correlation between the type of AIS and the out-of-control rate of treatment | Correlation between the type of AIS and the out-of-control rate of treatment | 36 months | |
Other | Correlation between the types of braces and the out-of-control rate of treatment | Correlation between the types of braces and the out-of-control rate of treatment | 36 months | |
Other | Correlation between the average time spent doing homework per day at baseline and the out-of-control rate of treatment | Correlation between the average time (hours) spent doing homework per day at baseline and the out-of-control rate of treatment | 36 months | |
Other | Correlation between the vitamin D content at baseline and the out-of-control rate of treatment | Correlation between the serum 25(OH)D (nmol/L) at baseline and the out-of-control rate of treatment | 36 months | |
Other | Correlation between the average time spent doing outdoor exercise after school per day at baseline and the out-of-control rate of treatment | Correlation between the average time (hours) spent doing outdoor exercise after school per day at baseline and the out-of-control rate of treatment | 36 months | |
Other | Correlation between the age and the change in 36-month Cobb angle from baseline | Correlation between the patient's age and the change in 36-month Cobb angle from baseline | 36 months | |
Other | Correlation between the BMI at baseline and the change in 36-month Cobb angle from baseline | Correlation between the patient's BMI (kg/m^2) at baseline and the change in 36-month Cobb angle from baseline | 36 months | |
Other | Correlation between the type of AIS and the change in 36-month Cobb angle from baseline | Correlation between the type of AIS and the change in 36-month Cobb angle from baseline | 36 months | |
Other | Correlation between the types of braces and the change in 36-month Cobb angle from baseline | Correlation between the types of braces and the change in 36-month Cobb angle from baseline | 36 months | |
Other | Correlation between the average time spent doing homework per day at baseline and the change in 36-month Cobb angle from baseline | Correlation between the average time (hours) spent doing homework per day at baseline and the change in 36-month Cobb angle from baseline | 36 months | |
Other | Correlation between the vitamin D content at baseline and the change in 36-month Cobb angle from baseline | Correlation between the serum 25(OH)D (nmol/L) at baseline and the change in 36-month Cobb angle from baseline | 36 months | |
Other | Correlation between the average time spent doing outdoor exercise after school per day at baseline and the change in 36-month Cobb angle from baseline | Correlation between the average time (hours) spent doing outdoor exercise after school per day at baseline and the change in 36-month Cobb angle from baseline | 36 months | |
Primary | Out-of-control rate of treatment | Among the patients with skeletal immaturity (Risser's sign 0, 1, 2), out-of-control rate of treatment at the follow-up to 36 months or at skeletal maturity during the trial (i.e., 4° for female Risser's sign or 5° for male Risser's sign). Out-of-control rate of treatment is defined as either: Cobb angle progression >5°, or Cobb angle =45°, or the physician recommends or already has enhanced the intervention regimen (i.e., no intervention change to exercise intervention, no intervention change to brace intervention, or exercise intervention change to brace intervention). | 36 months | |
Secondary | Change in SRS-22 score from baseline over time | Change in quality of life (SRS-22 score) from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment compared with those before treatment | at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment | |
Secondary | Change in vital capacity from baseline over time | Change in vital capacity from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment compared with those before treatment. | at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment | |
Secondary | Change in plantar pressure from baseline over time | Change in plantar pressure from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, and 36 months after treatment compared with those before treatment. | at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment | |
Secondary | Change in gait from baseline over time | Change in gait from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment compared with those before treatment | at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment | |
Secondary | Correlation between the treatment compliance and the out-of-control rate of treatment | Correlation between the treatment compliance (average daily duration of treatment for scoliosis) and the out-of-control rate of treatment | 36 months | |
Secondary | Correlation between the skeletal maturity at baseline and the out-of-control rate of treatment | Correlation between the skeletal maturity (Risser's sign) at baseline and the out-of-control rate of treatment | 36 months | |
Secondary | Correlation between the Cobb's angle at baseline and the out-of-control rate of treatment | Correlation between the Cobb's angle at baseline and the out-of-control rate of treatment | 36 months | |
Secondary | Correlation between the immediate correction and the out-of-control rate of treatment | Correlation between the immediate correction [(the baseline of Cobb angle - Cobb angle immediately after wearing the brace)/the baseline of Cobb angle] and the out-of-control rate of treatment | 36 months | |
Secondary | The incidence of adverse events | The incidence of adverse events for the intervention | 36 months | |
Secondary | The change in Cobb angle from baseline over time | The change in Cobb angle from baseline at 3 months, 6 months, 12 months, 18 months, 24 months, 30 months, 36 months after treatment compared with those before treatment | 36 months | |
Secondary | Correlation between the treatment compliance and the change in 36-month Cobb angle from baseline | Correlation between the treatment compliance (average daily duration of treatment for scoliosis) and the change in 36-month Cobb angle from baseline | 36 months | |
Secondary | Correlation between the skeletal maturity at baseline and the change in 36-month Cobb angle from baseline | Correlation between the skeletal maturity (Risser's sign) at baseline and the change in 36-month Cobb angle from baseline | 36 months | |
Secondary | Correlation between the immediate correction and the change in 36-month Cobb angle from baseline | Correlation between the immediate correction [(the baseline of Cobb angle - Cobb angle immediately after wearing the brace)/the baseline of Cobb angle] and the change in 36-month Cobb angle from baseline | 36 months | |
Secondary | Correlation between the Cobb's angle at baseline and the change in 36-month Cobb angle from baseline | Correlation between the Cobb's angle at baseline and the change in 36-month Cobb angle from baseline | 36 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05372016 -
Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
|
Phase 3 | |
Completed |
NCT03676101 -
Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
|
Phase 1 | |
Recruiting |
NCT04895020 -
Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Years
|
Phase 3 | |
Completed |
NCT04425291 -
Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
|
Phase 3 | |
Recruiting |
NCT05473975 -
Search for a Recanalization of the Sylvian Artery Electro-Physiological Biomarker
|
||
Completed |
NCT05496361 -
A Prospective, Multi-center and Randomized Controlled Trial of Tianyi Revascularization Device in Acute Ischemic Stroke
|
N/A | |
Completed |
NCT02905565 -
NBP in Adult Patients With Acute Ischemic Stroke (AIS)
|
Phase 2 | |
Recruiting |
NCT05152329 -
Investigating the Potential Psychological Impact of Early Screening and Long-term Monitoring for Adolescent Idiopathic Scoliosis Among Patients and Caregivers
|
||
Terminated |
NCT05584332 -
A Phase Ⅲ Study to Evaluate the Efficacy, Immunogenicity, Safety of Quadrivalent HPV Recombinant Vaccine in Chinese Healthy Females
|
Phase 3 | |
Active, not recruiting |
NCT06251505 -
Cervical Alignment Changes After Correction of Thoracic Adolescent Idiopathic Scoliosis With Thoracic Hypokyphosis
|
||
Recruiting |
NCT04422366 -
Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females
|
Phase 3 | |
Not yet recruiting |
NCT03105063 -
Evaluation of the AIIS Using Hip Ultrasound(AIISUS)
|
N/A |